Source: Annual Congress 2010 - Obstructive sleep apnoea syndrome and hypertension: guidelines for investigation and management
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
W. McNicholas (Dublin, Ireland). Mechanisms of the interaction between OSAS and hypertension. Annual Congress 2010 - Obstructive sleep apnoea syndrome and hypertension: guidelines for investigation and management

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis of hypertension in OSAS and in special populations Source: Annual Congress 2010 - Obstructive sleep apnoea syndrome and hypertension: guidelines for investigation and management Year: 2010 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Resistant arterial hypertension and obstructive sleep apnea syndrome Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010 Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006 Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Pathophysiology of OSA Source: Annual Congress 2012 - PG5 Obstructive sleep apnoea syndrome Year: 2012 Longterm follow-up of severe obstructive sleep apnea-hypopnea syndrome and prediction of systemic arterial hypertension Source: Annual Congress 2011 - Obstructive sleep apnoea in children and adults Year: 2011 Relationship between NT-proBNP level, echocardiographic parameters and cardiovascular diseases in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012 Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Role of obesity in asthma and COPD Source: Annual Congress 2011 - PG5 Asthma versus COPD: similarities and differences Year: 2011 Combined autoCPAP and acetazolamide treatment controls breathing disturbances in patients with obstructive sleep apnea syndrome at altitude Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research Year: 2010 Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 Mechanisms of the cerebrovascular response to apnea Source: Eur Respir J 2002; 20: Suppl. 38, 490s Year: 2002 Adiponectin is not a cardiovascular risk factor in otherwise healthy subjects with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Impact of obstructive sleep apnea and obesity on endothelial dysfunction in children Source: Virtual Congress 2020 – Respiratory physiology and sleep: from neonates to adults Year: 2020